Switch to:
Johnson & Johnson  (NYSE:JNJ) PS Ratio: 5.36 (As of Today)

As of today, Johnson & Johnson's share price is $140.68. Johnson & Johnson's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 was $26.27. Hence, Johnson & Johnson's P/S Ratio for today is 5.36.

Warning Sign:

Johnson & Johnson stock PS Ratio (=5.36) is close to 10-year high of 5.36

NYSE:JNJ' s PS Ratio Range Over the Past 10 Years
Min: 2.16   Max: 5.38
Current: 5.36

2.16
5.38

During the past 13 years, Johnson & Johnson's highest P/S Ratio was 5.38. The lowest was 2.16. And the median was 3.22.

NYSE:JNJ's PS Ratio is ranked lower than
65% of the 756 Companies
in the Global industry.

( Industry Median: 2.79 vs. NYSE:JNJ: 5.36 )

Johnson & Johnson's Revenue per Sharefor the three months ended in Jun. 2017 was $6.87. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 was $26.27.

Good Sign:

Johnson & Johnson has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Johnson & Johnson was 3.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 1.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.00% per year.

During the past 13 years, Johnson & Johnson's highest 3-Year average Revenue per Share Growth Rate was 14.80% per year. The lowest was 1.30% per year. And the median was 9.30% per year.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Johnson & Johnson Annual Data

Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.93 3.69 4.03 4.12 4.47

Johnson & Johnson Quarterly Data

Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
PS Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.79 4.61 4.47 4.79 5.04

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Calculation

The P/S Ratio is another ratio widely used to value stocks. It was first used by Ken Fisher.

Johnson & Johnson's P/S Ratio for today is calculated as

P/S Ratio=Share Price/Revenue per Share (TTM)
=140.68/26.266
=5.36

Johnson & Johnson's Share Price of today is $140.68.
Johnson & Johnson's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2017 was 6.398 (Sep. 2016 ) + 6.546 (Dec. 2016 ) + 6.45 (Mar. 2017 ) + 6.872 (Jun. 2017 ) = $26.27.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

It can also be calculated from the numbers for the whole company:


The revenue here is for the trailing 12 months.


Explanation

The P/S ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The P/S ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The P/S ratio is a great valuation tool for evaluating cyclical businesses where the P/E ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the P/S ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the Price/Earnings ratio and Price/Cash Flow or Price/Free Cash Flow, the P/E ratio measures the valuation based on the earning power of the company. This is where it is different from Price/Book ratio, which measures the valuation based on the company's balance sheet.


Be Aware

The P/S ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Related Terms


Headlines

From the Internet

JNJ
3 Stocks to Buy and Hold for 100 Years

- Fool 2017-10-18 21:00:00

JNJ
Dow ETFs Soar as the Index Hits 23,000

- Zacks 2017-10-18 15:19:00

JNJ
Impact Fasbs Pension Cost Accounting Rule Change

- Seekingalpha 2017-10-18 12:00:16

JNJ
16 61 Safer Dividend Healthcare Dogs October

- Seekingalpha 2017-10-18 11:23:24

JNJ
Johnson And Johnson Time Highs Time Sell Buy

- Seekingalpha 2017-10-18 10:25:06

JNJ
Stock Market News For Oct 18, 2017

- Zacks 2017-10-18 09:44:00

JNJ
Johnson And Johnson One Time Bumps

- Seekingalpha 2017-10-18 08:48:32

JNJ
Johnson And Johnson Q3 Beat Low Quality

- Seekingalpha 2017-10-18 08:22:59

JNJ
Markets May Cheaper Think Cramers Mad Money 10 17 17

- Seekingalpha 2017-10-18 07:39:22

JNJ
Johnson And Johnson Unsinkable

- Seekingalpha 2017-10-18 07:25:07

JNJ
Johnson And Johnson Amazing Company Something Wrong

- Seekingalpha 2017-10-17 23:17:11

JNJ
What Happened in the Stock Market Today

- Fool 2017-10-17 17:12:00

JNJ
Johnson & Johnson Jumps on Pharma Strength

- Fool 2017-10-17 13:18:00

JNJ
Why TransEnterix Stock Is Soaring Today

- Fool 2017-10-17 12:39:00

JNJ
J&J: Strong Earnings Is the Best Medicine

- Barron's 2017-10-17 10:13:00

JNJ
U.S. stocks open flat despite strong bank earnings

- MarketWatch 2017-10-17 09:33:00

JNJ
Market: Spectacular All Around

- Zacks 2017-10-17 09:20:00

JNJ
Wall Street Breakfast Dow Earnings Focus Amid Records

- Seekingalpha 2017-10-17 06:59:17

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK